drugset / Trial / NCT04853069
Oestrogen Treatment for COVID-19 Symptoms
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this trial is to determine whether oestrogen treatment mitigates disease progression and severity in confirmed COVID19.
Timeline
- Start
- 2021-05-17
- Primary completion
- 2022-02-28
- Completion
- 2022-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | 3 mg | Other |